Director's Share Options

RNS Number : 3011G

EKF Diagnostics Holdings PLC

28 June 2012

 



EKF Diagnostics Holdings plc

("EKF" or the "Company")

Director's Share Options

EKF Diagnostics Holdings plc (AIM: EKF), the growing in-vitro diagnostics company, announces that the Company has agreed to a 6 month extension of the exercise period relating to share options over 500,000 Ordinary Shares previously granted to Gordon Hall, Non-Executive Director of the Company, in 2005.

The latest date for the exercise of these options has been extended by 6 months from 28 June 2012 to 28 December 2012. The exercise price remains unchanged at 20 pence per Ordinary Share.

Enquiries:

EKF Diagnostics Holdings plc		Tel: [phone]
David Evans, Executive Chairman
Julian Baines, CEO
Canaccord Genuity Limited		Tel: [phone]
Jamie Adams / Mark Dickenson / Lucy Tilley
Walbrook PR Limited		Tel: [phone]
Paul McManus		Mob: [phone] or [e-mail]

 

END

 

 

RDSLLFIRRAIDFIF